Sixth International Congress

Drug Therapy in HIV Infection


17-21 November, 2002
Glasgow, UK


Print this article
Antiretroviral treatment for HIV-infected patients in developing countries

Michel Kazatchkine1
Int Cong Drug Therapy HIV 2002 Nov 17-21;6:Abstract No. KL1


[ABSTRACT:] The inequality between rich and poor nations in the treatment of HIVinfected people not only represents a moral scandal but has become a major economic political and social challenge that threatens world’s stability. A number of experts have assessed the obstacles to a faster access to treatment in the developing world and, for some, have advocated to favor prevention over treatment. This presentation will review the evidence supporting the wider use of antiretroviral drugs in resource limited setting, with a focus on the following issues: 1) access to antiretroviral treatments should facilitate rather than impede prevention efforts; 2) antiretroviral drugs can now be made available at differential and affordable prices in developing countries; 3) antiretroviral treatment can be cost effective in developing countries; 4) access to antiretroviral drugs will create support for strenghtening health care structures; 5) regulated efforts to improve access to antiretroviral treatment should reduce inequality with regard to access to care; 6) there are now examples demonstrating that antiretroviral treatment in developing countries is effective and well tolerated and that it is not associated with a higher incidence of resistence than in the North. We have reached a turning point in AIDS where access to antiretroviral treatment for HIV-infected individuals in developing countries can no longer be refused on grounds of cost, lack of infrastructures, political or other priorities.

Presenting author: Michel Kazatchkine

Download Conferences Abstracts

1Agence Nationale de Recherches sur le Sida, Paris, France

2002-11-17
KL1

Copyright © 2002 - The Gardiner-Caldwell Group, Ltd.. All Rights Reserved. Reproduction of this abstract (other than one copy for personal reference) must be cleared through the Sixth International Congress on Drug Therapy in HIV Infection, c/o The Gardiner-Caldwell Group Ltd, part of The Thomson Corporation, Peakside House, Alder Court, Tytherington Business Park, Tytherington, Cheshire SK10 2XG, UK - Tel: +44 (0)1625 668000, Fax: +44 (0)1625 668121 Email: hiv6@gardiner-caldwell.com

This information is designed to support, not replace, the relationship that exists between you and your doctor. ©1980, 2005. AEGiS.